{
    "code": "52026500",
    "time": "2015-08-28 04:43:03",
    "許可證字號": "衛部藥輸字第026500號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "109\/06\/01",
    "發證日期": "104\/06\/01",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202650009",
    "中文品名": "英克賜易利達55 mcg乾粉吸入劑",
    "英文品名": "Incruse Ellipta 55 mcg Inhalation Powder",
    "適應症": "慢性阻塞性肺病(COPD)患者之氣道阻塞症狀的維持治療",
    "劑型": "407乾粉吸入劑",
    "包裝": "7、30劑量塑膠殼裝 含劑量計數之吸入器",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "Umeclidinium bromide (micronised)",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "6201011338  荷商葛蘭素史克藥廠股份有限公司台灣分公司",
    "申請商地址": "台北市中正區忠孝西路一段66號23-24樓",
    "主製造廠": {
        "製造廠名稱": "F130044900  GLAXO OPERATIONS UK Limited",
        "製造廠廠址": "PRIORY STREET, WARE, HERTFORDSHIRE SG12 0DJ, UNITED KINGDOM.",
        "製造廠公司地址": "",
        "製造廠國別": "UNITED KINGDOM",
        "製程": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1212005410",
            "成分名稱": "Umeclidinium bromide (micronised)",
            "含量描述": "",
            "含量": "74.2000000000",
            "單位": "MCG"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 020265000001-104-06-24.pdf 020265000001-104-06-24.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=52026500&Seq=002&Type=9"
        },
        {
            "title": "外盒 020265000006-104-06-24.pdf 020265000005-104-06-24.pdf 020265000004-104-06-24.pdf 020265000003-104-06-24.pdf 020265000006-104-06-24.pdf 020265000005-104-06-24.pdf 020265000004-104-06-24.pdf 020265000003-104-06-24.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=52026500&Seq=008&Type=8"
        }
    ]
}